Mutagenic activation of aflatoxin B1 by P-450 HFLa in human fetal livers
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Mutation Research Letters
- Vol. 227 (1), 53-58
- https://doi.org/10.1016/0165-7992(89)90068-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Metabolic activation of environmental carcinogens and mutagens by human liver microsomesBiochemical Pharmacology, 1988
- Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomesToxicology and Applied Pharmacology, 1987
- Cytochrome P-450-mediated activation of pro-carcinogens and promutagens to DNA-damaging products by measuring expression of umu gene in Salmonella typhimurium TA1535/pSK1002Biochemical Pharmacology, 1987
- Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidationsBiochemical Pharmacology, 1987
- Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450Mutation Research Letters, 1986
- Metabolic activation of mutagenic heterocylic aromatic amines from protein pyrolysatesCRC Critical Reviews in Toxicology, 1986
- Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresisBiochemistry, 1982
- Partial purification and characterization of cytochrome P-450 responsible for the occurrence of sex difference in drug metabolism in the ratBiochemical and Biophysical Research Communications, 1981
- Drug Metabolism by the Human FetusClinical Pharmacokinetics, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970